Class 4 caution in use-Zoledronic acid 4mg/5ml Solution

Ennogen Healthcare Limited has identified that action had not been taken to ensure the Patient Reminder Card (PRC) was distributed alongside the packs of product as part of the approved Additional Risk Minimisation Measures (RMM).

MHRA Drug alert date: 7th November 2024

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ennogen-healthcare-limited-zoledronic-acid-ennogen-4mg-slash-5ml-concentrate-for-solution-for-infusion-el-24-a-slash-53?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ae0d646e-30a4-4189-8027-c36d2c450c0b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact MedicalInformation@ennogen.com

For stock control enquiries please telephone +44 (0)1322 629220